Journal article

MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: A combined analysis of two randomized, double-blind, placebo-controlled trials

WJ Sandborn, MA Kamm, GR Lichtenstein, A Lyne, T Butler, RE Joseph

Alimentary Pharmacology and Therapeutics | Published : 2007

Citation metrics